FibroGen Inc Strategic Asset Allocation Index
FibroGen Inc strategic asset allocation index. FibroGen Inc (FGEN) has a Strategic Asset Allocation Index of 17.4% as of September 2025. Strategic assets (PP&E of $- plus long-term investments of $3.04 Million) total $3.04 Million, measured against net assets of $17.48 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See FibroGen Inc net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of FibroGen Inc (2012–2021)
Strategic asset allocation index of FibroGen Inc from 2012 to 2021. This chart shows how FibroGen Inc's Strategic Asset Allocation Index has evolved across 10 annual periods from 2012 to 2021. As of September 2025, the index stands at 17.4%, representing strategic assets of $3.04 Million against net assets of $17.48 Million USD. Check FibroGen Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
FibroGen Inc Strategic Asset Allocation Index by Year (2012–2021)
FibroGen Inc strategic asset allocation index by year from 2012 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for FibroGen Inc from 2012 to 2021, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see FibroGen Inc stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 127.3% | $291.77 Million | $120.15 Million | $171.62 Million | $229.11 Million | ▲ +119.7 pp |
| 2020 | 7.7% | $33.89 Million | $33.65 Million | $244.00K | $441.45 Million | ▼ -11.7 pp |
| 2019 | 19.4% | $103.86 Million | $42.74 Million | $61.12 Million | $535.41 Million | ▼ -15.2 pp |
| 2018 | 34.6% | $183.02 Million | $127.20 Million | $55.82 Million | $528.47 Million | ▲ +10.6 pp |
| 2017 | 24.0% | $139.98 Million | $129.48 Million | $10.51 Million | $582.45 Million | ▼ -87.1 pp |
| 2016 | 111.2% | $194.67 Million | $123.66 Million | $71.01 Million | $175.11 Million | ▼ -21.3 pp |
| 2015 | 132.5% | $260.74 Million | $129.02 Million | $131.72 Million | $196.82 Million | ▲ +17.6 pp |
| 2014 | 114.9% | $276.44 Million | $132.17 Million | $144.27 Million | $240.68 Million | ▼ -5.9 pp |
| 2013 | 120.7% | $129.90 Million | $129.90 Million | $- | $107.60 Million | ▲ +19.5 pp |
| 2012 | 101.2% | $123.66 Million | $123.66 Million | $- | $122.18 Million | — |